Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 … – GlobeNewswire (press release)
GlobeNewswire (press release) |
Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 …
GlobeNewswire (press release) CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company developing curative therapeutics using CRISPR/Cas9 technology, announced that Cell Reports will publish at noon ET today its … Intellia Therapeutics (NTLA) Stock Price Up 11.1% Intellia Therapeutics (NTLA) Shares Up 11.1% Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Intellia Therapeutics (NTLA) Share Price |
